Abstract
Objects: With the advent of genetic technologies, many genetic/metabolic disorders can be detected asymptomatically but might be untreatable, and the benefits and risks of screening for them are not fully known. The purpose of this study is to explore current practice with regard to the parental consent process in newborn screening (NBS).
Design: Staff in 23 obstetric clinics/hospitals that conduct NBS in one city of southern Taiwan were interviewed. Using content analysis, 15 interview transcripts, eight completed questionnaires, and other relevant documents from the 23 clinics/hospitals were analysed to reveal the framework of the parental consent process in NBS in southern Taiwan.
Main measures: Three categories—informed consent, informed dissent, and no informed/consent—were developed to analyse the parental consent process in NBS.
Results: The parental consent procedures in NBS and the quality of the information provided before obtaining consent vary widely. Because the traditional NBS was incorporated into routine paediatric practices in most clinics/hospitals, the most frequently encountered consent model is "informed dissent" (60.9%) and "no informed/consent" (30.4%); while an "informed consent" model (45.5%) is the frequent model for screening rare metabolic/genetic disorders.
Conclusions: Specific guidelines to regulate the parental consent process for NBS are essential. Further studies should investigate parental responses to NBS, taking these as the basis on which to establish an informed consent model in Taiwan.
Full Text
The Full Text of this article is available as a PDF (57.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chadwick R., ten Have H., Husted J., Levitt M., McGleenan T., Shickle D., Wiesing U. Genetic screening and ethics: European perspectives. J Med Philos. 1998 Jun;23(3):255–273. doi: 10.1076/jmep.23.3.255.2580. [DOI] [PubMed] [Google Scholar]
- Fost N. Ethical issues in genetics. Pediatr Clin North Am. 1992 Feb;39(1):79–89. doi: 10.1016/s0031-3955(16)38264-5. [DOI] [PubMed] [Google Scholar]
- Huang Mei-Chih, Lin Shio-Jean. Newborn screening: should explicit parental consent be required? Acta Paediatr Taiwan. 2003 May-Jun;44(3):126–129. [PubMed] [Google Scholar]
- Lloyd-Puryear Michele A., Forsman Irene. Newborn screening and genetic testing. J Obstet Gynecol Neonatal Nurs. 2002 Mar-Apr;31(2):200–207. doi: 10.1111/j.1552-6909.2002.tb00041.x. [DOI] [PubMed] [Google Scholar]
- McQueen Matthew J. Some ethical and design challenges of screening programs and screening tests. Clin Chim Acta. 2002 Jan;315(1-2):41–48. doi: 10.1016/s0009-8981(01)00719-7. [DOI] [PubMed] [Google Scholar]
- Wildeman S., Downie J. Genetic and metabolic screening of newborns: must health care providers seek explicit parental consent? Health Law J. 2001;9:61–111. [PubMed] [Google Scholar]